TSHA:

$5.81

-0.94%

Taysha Gene Therapies, Inc.

USD as of Aug 3, 2026 | NASDAQ - NASDAQ Global Select

Company Profile NASDAQ Composite Russell 2000 Russell 3000

1-Year Price Evolution & Moving Averages

1-Year: +120.72%

Multi-timeframe price chart with technical indicators - United States dollar (USD)

Company Description

Company Profile

Taysha Gene Therapies, Inc. develops gene therapy treatments for rare central nervous system diseases and other neurological disorders.

United States Healthcare Biotechnology US Healthcare US Biotechnology

Risk & Valuation

as of Aug. 1, 2026

Beta	1.16
Trailing PE	2.53
Forward PE	-13.47

Stock Data

Open	$5.89
High	$5.95
Low	$5.63
Close	$5.81
Volume	245,280
Previous Close	$5.86
1-Day Change	-0.06
1-Year Change	+3.17
Average Daily Volume	3,808,075
52-Week High	$6.98
52-Week Low	$2.63

Disclaimer

All information and data available on Disfold is NOT FINANCIAL ADVICE. Invest at your own risk!

Past performance is not a guarantee of future performance. Patterns tend to repeat themselves, but they don't necessarily have to.

Furthermore, even though Disfold strives to provide the best and most accurate data, errors can occur in Disfold's systems, or in our data providers' systems.

Please conduct your own due diligence to verify insights.